Nagendran Sukumar bought TSHA

April 10, 2026 · Form 4 insider transaction

Nagendran Sukumar bought 19,021 shares of Taysha Gene Therapies, Inc. at $1.71 per share, a transaction worth $32.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.